These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 12799248

  • 1. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy.
    Hayreh SS, Zimmerman B.
    Ophthalmology; 2003 Jun; 110(6):1204-15. PubMed ID: 12799248
    [Abstract] [Full Text] [Related]

  • 2. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies.
    Hayreh SS, Zimmerman B.
    Ophthalmologica; 2003 Jun; 217(4):239-59. PubMed ID: 12792130
    [Abstract] [Full Text] [Related]

  • 3. Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Danesh-Meyer H, Savino PJ, Gamble GG.
    Ophthalmology; 2005 Jun; 112(6):1098-103. PubMed ID: 15885780
    [Abstract] [Full Text] [Related]

  • 4. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.
    Hayreh SS, Zimmerman B, Kardon RH.
    Acta Ophthalmol Scand; 2002 Aug; 80(4):355-67. PubMed ID: 12190776
    [Abstract] [Full Text] [Related]

  • 5. Recovery of visual function in patients with biopsy-proven giant cell arteritis.
    Foroozan R, Deramo VA, Buono LM, Jayamanne DG, Sergott RC, Danesh-Meyer H, Savino PJ.
    Ophthalmology; 2003 Mar; 110(3):539-42. PubMed ID: 12623817
    [Abstract] [Full Text] [Related]

  • 6. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
    Jakobsson K, Jacobsson L, Mohammad AJ, Nilsson JÅ, Warrington K, Matteson EL, Turesson C.
    BMC Musculoskelet Disord; 2016 Aug 24; 17(1):363. PubMed ID: 27558589
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
    Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, Eggenberger E, Antonio-Santos A, Golnik K, Kardon R, Wall M.
    Ophthalmology; 2006 Oct 24; 113(10):1842-5. PubMed ID: 16884778
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Scalp necrosis with giant cell arteritis.
    Dudenhoefer EJ, Cornblath WT, Schatz MP.
    Ophthalmology; 1998 Oct 24; 105(10):1875-8. PubMed ID: 9787357
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.
    Kupersmith MJ, Langer R, Mitnick H, Spiera R, Spiera H, Richmond M, Paget S.
    Br J Ophthalmol; 1999 Jul 24; 83(7):796-801. PubMed ID: 10381666
    [Abstract] [Full Text] [Related]

  • 15. Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone.
    Cornblath WT, Eggenberger ER.
    Ophthalmology; 1997 May 24; 104(5):854-8. PubMed ID: 9160034
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Incidence of discordant temporal artery biopsy in the diagnosis of giant cell arteritis.
    Durling B, Toren A, Patel V, Gilberg S, Weis E, Jordan D.
    Can J Ophthalmol; 2014 Apr 24; 49(2):157-61. PubMed ID: 24767221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.